Ipamorelin vs. Sermorelin: Two Receptors, One Outcome

Ipamorelin and sermorelin are compared constantly and are not really alternatives. They act on two different receptors that converge on the same output: growth hormone release from the pituitary.

That is why the usual recommendation is not to choose between them but to use both.

Side by side

Two doors into the same room

The pituitary releases growth hormone in response to two separate signals. GHRH from the hypothalamus is one; ghrelin acting on GHS-R1a is the other.

Sermorelin mimics the first. Ipamorelin mimics the second. Because the receptors are distinct and their signalling is not redundant, activating both is expected to produce more release than either alone — which is the entire rationale for pairing a GHRH analogue with a GHRP.

What ipamorelin’s selectivity buys

Ipamorelin was described in its foundational 1998 paper as the first selective growth hormone secretagogue — prompting GH release without the cortisol and prolactin increases seen with earlier GHRPs.

That property is the reason it is preferred over hexarelin, which produces a larger GH response and lacks the selectivity. Potency without selectivity means everything else the receptor family does comes along.

What sermorelin’s history buys

Sermorelin was an approved medicine before being withdrawn, reportedly for commercial reasons. That means a labelled dose once existed for it — unusual in this category, where most figures are extrapolations.

It does not mean current material is regulated. See the sermorelin guide and, for the longer-acting GHRH analogue, tesamorelin vs sermorelin.

The vial math

Both are microgram-scale, so generous dilution gives more readable numbers. The peptide calculator handles any combination.

Storage

Storage is the same as any reconstituted vial: 2–8 °C, protected from light, never frozen, and bounded by the shorter of peptide stability and the 28-day limit on bacteriostatic water. The bacteriostatic water guide covers the detail.

Frequently asked questions

Which one should I choose?

They are not substitutes — different receptors, complementary rather than competing. The common approach is a GHRH analogue plus a GHRP rather than either alone.

Is ipamorelin stronger?

It has a longer half-life and acts on a different receptor. "Stronger" does not translate cleanly between two compounds working through separate pathways.

Do either build muscle?

Both raise growth hormone. That this produces meaningful muscle growth in healthy adults is not established — see peptides for muscle growth.